Palatin Technologies(PTN)
CRANBURY, NJ
BiotechnologyFocus: Small Molecules
Palatin Technologies is a life sciences company focused on Small Molecules.
OphthalmologyCardiovascularRespiratoryNephrologyImmunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Bremelanotide
Sexual Arousal DisorderBremelanotide
Kidney DiseaseClinical Trials (1)
NCT05709444A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
Phase 2PL8177 Placebo
Ulcerative ColitisClinical Trials (1)
NCT05466890Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)
Phase 2bremelanotide
Female Sexual Arousal DisorderClinical Trials (1)
NCT01382719Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder
Phase 2PL-3994 Aqueous Intravenous Solution Dose Ascention
Heart Failure With Preserved Ejection FractionClinical Trials (1)
NCT04318145Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Phase 2PL-3994
AsthmaClinical Trials (1)
NCT01304628Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma
Phase 2bremelanotide
ObesityClinical Trials (1)
NCT06565611A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity
Phase 2PL9643 Ophthalmic Solution
Dry Eye DiseaseClinical Trials (1)
NCT04268069Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
Phase 2PL3994
HypertensionClinical Trials (1)
NCT00686803Safety Study of Subcutaneously Administered PL-3994 in Subjects With Controlled Hypertension
Phase 2Bremelanotide
Hypoactive Sexual Desire DisorderClinical Trials (1)
NCT023389602. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Phase 3Vehicle Ophthalmic Solution
Dry EyeClinical Trials (1)
NCT05201170A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye
Phase 3Bremelanotide
Hypoactive Sexual Desire DisorderClinical Trials (1)
NCT023330711. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 1997
Portfolio: 11 clinical trials
SEC Filings: 2 available